Penn Medicine & CHOP were instrumental in developing ‘breakthrough’ gene therapy – LancasterOnline
LancasterOnline |
Penn Medicine & CHOP were instrumental in developing 'breakthrough' gene therapy
LancasterOnline The Food and Drug Administration has approved the first treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia. Here's a look at how the powerful CAR-T cell therapy works. (Aug. 30). FDA approves new gene therapy treatment for leukemia developed by Penn Medicine and CHOP |
